Cite
HARVARD Citation
Wei, S. et al. (n.d.). P425 Real-world evidence on effectiveness and safety of vedolizumab therapy for inflammatory bowel disease in Taiwan: Results from the TSIBD registry (VIOLET Study). Journal of Crohn's and colitis. pp. S428-S430. [Online].